List Alan's Form 4 filing
Precision Biosciences Inc (DTIL) · filed Jan 23, 2024
- Accession no.
- 0001209191-24-002115
- Filed
- Jan 23, 2024, 7:13 PM ET
- Trade date
- Jan 20-22, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $7.75K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| List AlanCIK 0001858530 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 20, 2024 | Common Stock | MOption exerciseAcquired | +60,012 | – | – | 116,508 | Direct | |
| Jan 22, 2024 | Common Stock | SSaleDisposed | −21,526 | $0.36 | −$7,749.36 | 94,982 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 20, 2024 | Common Stock | MOption exerciseDisposed | −60,012 | $0.00 | $0 | 119,988 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.